Latest filing published 05 Jun 2025 for Aspira Women's Health Inc.. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
This profile gathers the share dealings of Ellen Beausang in Aspira Women's Health Inc. The record holds 2 filings, for trades running from 31 March 2025 to 4 June 2025.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 5 June 2025, reports an option exercise in Aspira Women's Health Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations